Cramer: Hewlett's Back
Health Care: Drugs
GlaxoSmithKline PLC (GSK: NYSE)
$52.73 -0.21 | -0.40%
05/23/13 - 04:02 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 7.67B | 8.47B | 2.86B | 9.17B |
| Operating Gains/Losses | 2.02B | -1.29B | 2.77B | 3.04B |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 252.10M | 190.97M | 1.41B | -981.52M |
| (Increase) Decrease in Inventories | 59.79M | -243.76M | 367.33M | -213.44M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 286.03M | 686.25M | 237.68M | 1.47B |
| (Decrease) Increase In Other Current Liabilities | 0.00 | -3.39B | 2.55B | -517.44M |
| (Increase) Decrease In Other Working Capital | -4.52B | 3.11M | -276.27M | 0.00 |
| Other Non-Cash Items | 1.68B | 3.06B | -2.02B | -1.81B |
| Net Cash From Continuing Operations | 7.07B | 9.70B | 10.49B | 12.68B |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 7.07B | 9.70B | 10.49B | 12.68B |
| Sale of Property, Plant & Equipment | 1.82B | 523.23M | 336.46M | 653.27M |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 46.58M | 140.45M | 0.00 |
| Purchases of Property, Plant & Equipment | -2.46B | -2.06B | -2.52B | -3.03B |
| Acquisitions | -3.61B | -409.89M | -546.36M | -4.51B |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 114.74M | 1.68B | 192.93M | 601.52M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -4.25B | -173.89M | -2.88B | -6.49B |
| Issuance of Debt | 9.98B | 69.87M | 9.26M | 3.24B |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 669.03M | 458.02M | 121.93M | 90.55M |
| Repayment of Long-Term Debt | -4.19B | -71.42M | -2.07B | -1.29B |
| Repurchase of Capital Stock | -4.09B | -3.46B | -24.69M | -92.17M |
| Payment of Cash Dividends | -6.44B | -5.65B | -4.95B | -5.00B |
| Other Financing Charges, Net | -1.34B | -1.02B | -1.69B | -1.44B |
| Net Cash From Financing Activities | -5.42B | -9.68B | -8.60B | -4.49B |
| Effect of Exchange Rate Changes | -148.67M | -167.68M | 125.02M | -255.49M |
| Net Change in Cash & Cash Equivalents | -2.75B | -313.63M | -865.85M | 1.45B |
Portfolios with GSK
- Portfolio NameUser Type
- Usersamuel sandler kosher sausage
- ContributorStocks Rising On Unusual Vo...
- ProBill Miller - Legg Mason Ca...
- ProKen Fisher - Fisher Investm...
- Usercurrent holdings
- Contributor7 Big-Pharma Stocks With Un...
- Contributor10 Dividend Stocks Held by ...
- UserKAREL VON ZOETE
- UserMARIA DEL HUERTO
- ContributorHighest-Yielding Drug Stocks
Latest GSK Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Ignore the Fed 05.22.13 | 07:05 pm
- Benefiting From the Rotation To Cyclicals
05.22.13 | 11:05 am - New Home Demand Drives Toll 05.22.13 | 11:05 am
- Toll Reports Better-than-Expected Earnings: Ahead of the Ticker 05.22.13 | 09:05 am
- GlaxoSmithKline Stock Hits New 52-Week High (GSK) 05.21.13 | 11:05 am
- 2013 FDA Drug Approval Calendar 05.21.13 | 07:05 am
- Aveo Screwed Up But Its Kidney Cancer Drug Is Real 05.15.13 | 08:05 am
- GlaxoSmithKline PLC Stock Buy Recommendation Reiterated (GSK) 05.14.13 | 10:05 am
- 4 Buy-Rated Dividend Stocks: HME, GSK, EPR, HPT 05.10.13 | 11:05 am
- GlaxoSmithKline Stock To Go Ex-dividend Tomorrow (GSK) 05.07.13 | 09:05 am
Press Releases for GSK
- FDA Advisory Committee Recommends Approval Of BREOâ¿¢ ELLIPTAâ¿¢ For The Treatment Of COPD - PR Newswire 04.17.13 | 05:04 pm
- GlaxoSmithKline, Triangle Community Foundation Issue Call For Applications Totaling $400,000 In GSK IMPACT Awards - PR Newswire 04.17.13 | 11:04 am
- GlaxoSmithKline Issues Call For Applications Totaling $400,000 In GSK IMPACT Awards - PR Newswire 04.17.13 | 11:04 am
- GlaxoSmithKline And Liberty Property Trust/Synterra Partners Transform The Work Environment With The Opening Of Five Crescent Drive Today - PR Newswire 04.06.13 | 06:04 pm
- GlaxoSmithKline And Liberty Property Trust/Synterra Partners Transform The Work Environment With The Opening Of Five Crescent Drive - PR Newswire 04.05.13 | 10:04 am
- Texas A&M System And GlaxoSmithKline Receive U.S. Government Approval To Establish Influenza Vaccine Facility In Texas - PR Newswire 03.26.13 | 11:03 am
- Americans Rate Themselves And Their Communities As Healthy, Despite Research Showing The Opposite - PR Newswire 03.06.13 | 09:03 am
- GlaxoSmithKline Progresses Multi-city Discussion Focused On Improving The Health Of US Communities - PR Newswire 02.06.13 | 09:02 am
- FDA Approves GlaxoSmithKline's Four-strain Seasonal Influenza Vaccine For Use In The U.S. - PR Newswire 12.17.12 | 10:12 am
- GSK Receives FDA Approval For Raxibacumab Anti-toxin For The Treatment Of Inhalational Anthrax - PR Newswire 12.14.12 | 05:12 pm
Partner Headlines for GSK
- Muscular Dystrophy Drug Succeeds, Sarepta Buyers Flood In - Seeking Alpha 04.11.13 | 09:04 am
- Parexel Grows Earnings With Big Pharma Partnerships - Investor's Business Daily 04.04.13 | 02:04 pm
- Curing Parkinson's: The Alternative Approach - Is There Money To Be Made? - Seeking Alpha 04.04.13 | 09:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- 5 Dividends Stocks From Billionaire Ken Fisher - Seeking Alpha 03.28.13 | 09:03 am
- Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind - Seeking Alpha 03.25.13 | 09:03 am
- Top 9 March Healthcare Dogs Mark 3.4% To 28.7% Gains - Seeking Alpha 03.23.13 | 04:03 am
- Valeant Earnings, Sales Top Estimates; Street Shrugs - Investor's Business Daily 02.28.13 | 05:02 pm
- Roche Breast Cancer Drug To Succeed Herceptin - Investor's Business Daily 02.22.13 | 04:02 pm
- GlaxoSmithKline PLC (GSK) Ex-Dividend Date Scheduled for February 20, 2013 - NASDAQ 02.15.13 | 02:02 pm
